Gentilcore Douglas J 4
4 · Y-mAbs Therapeutics, Inc. · Filed Jan 22, 2025
Insider Transaction Report
Form 4
Gentilcore Douglas J
SVP, Danyelza Bus. Unit Head
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-17+142,600→ 142,600 totalExercise: $6.16Exp: 2035-01-17→ Common Stock (142,600 underlying)
Footnotes (2)
- [F1]Represents stock options granted to the Reporting Person pursuant to the Issuer's 2018 Equity Incentive Plan.
- [F2]The stock options shall vest and become exercisable as to 25% of the shares subject to the option on January 17, 2026, and thereafter vest and become exercisable as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.